All Stories

  1. Detrimental Influence of Alveolar Macrophages on Protective Humoral Immunity during Francisella tularensis SchuS4 Pulmonary Infection
  2. Protective Role for Macrophages in Respiratory Francisella tularensis Infection
  3. Role of Interleukin-12 in Protection against Pulmonary Infection with Methicillin-Resistant Staphylococcus aureus
  4. Allergic Lung Inflammation Reduces Tissue Invasion and Enhances Survival from Pulmonary Pneumococcal Infection in Mice, Which Correlates with Increased Expression of Transforming Growth Factor β1 and SiglecFlowAlveolar Macrophages
  5. Expression of Suppressor of Cytokine Signaling 1 (SOCS1) Impairs Viral Clearance and Exacerbates Lung Injury during Influenza Infection
  6. Detection of cyclic di-AMP using a competitive ELISA with a unique pneumococcal cyclic di-AMP binding protein
  7. Host–pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicity
  8. Does Type I Interferon Limit Protective Neutrophil Responses during Pulmonary Francisella Tularensis Infection?
  9. Asthma Increases Susceptibility to Heterologous but Not Homologous Secondary Influenza
  10. Acquired Immunity: Acute Bacterial Infections
  11. Use and Misuse of Statistical Significance in Survival Analyses
  12. Increased Susceptibility of IgA-Deficient Mice to Pulmonary Francisella tularensis Live Vaccine Strain Infection
  13. Identification of a Live Attenuated Vaccine Candidate for Tularemia Prophylaxis
  14. Differing Effects of Interleukin-10 on Cutaneous and Pulmonary Francisella tularensis Live Vaccine Strain Infection
  15. Galectin-3 Functions as an Alarmin: Pathogenic Role for Sepsis Development in Murine Respiratory Tularemia
  16. Rational Design of Pathogen-Mimicking Amphiphilic Materials as Nanoadjuvants
  17. Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia
  18. Design of a Protective Single-Dose Intranasal Nanoparticle-Based Vaccine Platform for Respiratory Infectious Diseases
  19. Interleukin-12 as an adjuvant for induction of protective antibody responses
  20. Antistaphylococcal Nanocomposite Films Based on Enzyme−Nanotube Conjugates
  21. Emerging Roles of T Helper Subsets in the Pathogenesis of Asthma
  22. IL-12 as an adjuvant for the enhancement of protective humoral immunity
  23. Humoral and cell‐mediated immunity to the intracellular pathogen Francisella tularensis
  24. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain
  25. Inhibition of pulmonary antibacterial defense by interferon-γ during recovery from influenza infection
  26. Mouse models for the study of mucosal vaccination against otitis media
  27. Intranasal vaccination of infant mice induces protective immunity in the absence of nasal-associated lymphoid tissue
  28. IgA and Respiratory Immunity
  29. Immune Response to Small Intestinal Submucosa (Surgisis) Implant in Humans: Preliminary Observations
  30. Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media
  31. Azithromycin Modulates Murine Immune Responses to Pneumococcal Conjugate Vaccine and Inhibits Nasal Clearance of Bacteria
  32. Early activation of NK cells after lung infection with the intracellular bacterium, Francisella tularensis LVS
  33. Delivery of IL-12 intranasally leads to reduced IL-12-mediated toxicity
  34. Immune Response to Engineered Tissues and Cells
  35. Immune Responses to Tissue-Engineered Extracellular Matrix Used as a Bioscaffold
  36. Immunological Concerns with Bioengineering Approaches
  37. Natural anti-galactose α1,3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenografts
  38. The Th2-Restricted Immune Response to Xenogeneic Small Intestinal Submucosa Does Not Influence Systemic Protective Immunity to Viral and Bacterial Pathogens
  39. Frequency- and Duration-Dependent Effects of Cyclic Pressure on Select Bone Cell Functions
  40. XENOGENEIC EXTRACELLULAR MATRIX GRAFTS ELICIT A TH2-RESTRICTED IMMUNE RESPONSE1
  41. IL-12-mediated increases in protection elicited by pneumococcal and meningococcal conjugate vaccines
  42. Interleukin-12 enhances clinical experimental autoimmune myasthenia gravis in susceptible but not resistant mice
  43. A Pivotal Role for Interferon‐γ in Protection against Group A Streptococcal Skin Infection
  44. Intranasal Interleukin‐12 is a Powerful Adjuvant for Protective Mucosal Immunity
  45. Modulation of mucosal and systemic immunity by intranasal interleukin 12 delivery
  46. IL-12 is a potent neonatal vaccine adjuvant
  47. Interleukin‐12 acts as an adjuvant for humoral immunity through interferon‐γ‐dependent and ‐independent mechanisms
  48. Enhancement of Humoral Immunity by Interleukin‐12
  49. Inhibition of murine B1 lymphocytes by interleukin-12
  50. Direct binding of IL-12 to human and murine B lymphocytes
  51. Approaches for the Study of T-Cell Influences on B1-Cell Function
  52. The rabbit B cell antigen receptor is non-covalently associated with unique heteromeric protein complexes: Possible insights into the membrane IgM/IgD coexpression paradox
  53. Antibody Response of Murine B1 Cells to Hen Eggwhite Lysozyme
  54. Back to front
  55. Interleukin 12 alters the isotype-restricted antibody response of mice to hen eggwhite lysozyme
  56. ANTIBODY-BINDING BACTERIAL PROTEINS AS IMMUNOREAGENTS
  57. ENHANCED SKIN ALLOGRAFT SURVIVAL AFTER PHOTODYNAMIC THERAPY
  58. Use of antibodies for analysis of bacterial proteins
  59. Applications of Bacterial Immunoglobulin-Binding Proteins to the Purification of Immunoglobulins
  60. Preparative Isolation of Murine CD5 B Cells by Panning and Magnetic Beadsa
  61. Epitope Mapping and Idiotypy of the Antibody Response to Influenza Neuraminidase
  62. Epitope Mimicry by Anti-Idiotype Sequences in Reverse Orientation
  63. In vivo activation of quiescent B cells by nnti-immunoglubulin
  64. Heating of immunoglobulins for immunoblot analysis destroys variable region antigenicity
  65. Mouse monoclonal antibodies induced by anti‐allotype antibody display internal images of the rabbit VHa1 allotype: Direct visualization by immunoelectron microscopy
  66. Characterization of a monoclonal antibody reactive with rabbit T lymphocytes and neutrophils
  67. Second International Workshop on Immunogenetics and immunobiology of the rabbit
  68. A mouse monoclonal antibody against rabbit VH allotype shares the predominant idiotype with a rabbit antibody of the same specificity
  69. Induced latent allotypes within rabbit anti‐crossreactive idiotype reagents. Direct immunoelectron microscopic evidence
  70. The expressed lysozyme‐specific B cell repertoire I. Heterogeneity in the monoclonal anti‐hen egg white lysozyme specificity repertoire, and its difference from the in situ repertoire
  71. Anti‐immunoglobulin antibodies IV. Cross‐reaction of anti‐idiotypic antibodies specific for rabbit and murine anti‐a1 allotype antibodies with Fc fragment of human immunoglobulins
  72. Shared and Nonshared Idiotypes on Rabbit Anti‐Allotype Antibodiesa
  73. The Design of Regulatory Circuitry: Predominant Idiotypy and the Idea of Regulatory Parsimonya
  74. A monoclonal antibody (SJ-9A4) to P24 present on common ALLS, neuroblastomas and platelets — I. Characterization and development of a unique radioimmunometric assay
  75. IMMUNOELECTRON MICROSCOPIC ANALYSIS OF THE IMMUNOGLOBULIN MOLECULE FOR IDIOTYPES AND ALLOTYPES
  76. Sharing of an idiotypic marker by monoclonal antibodies specific for distinct regions of hen lysozyme
  77. Epitope-specific and idiotype-specific cellular interactions in a model protein antigen system
  78. Primary in vitro antibody response of rabbit lymphoid cells and T-B cell collaboration in the absence of detectable mitogens